NOT FOR DISTRIBUTION OR RELEASE, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN
OR INTO THE UNITED STATES OF AMERICA, THE UNITED KINGDOM, AUSTRALIA, CANADA,
HONG KONG OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR
RELEASE WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY
OF THE SECURITIES DESCRIBED HEREIN. 

Reference is made to the stock exchange announcement published by SoftOx
Solution AS (the "Company") on September 17th and 18th, 2024, regarding
increasing the share capital by converting outstanding claims to new shares in
the Company.

The following primary insiders and close associates to primary insiders have
been allocated new shares:

Hermod Farms AS, a company owned by Geir Almås, has been allocated 58 326 042
shares in the Company. As a result, Geir Almås together with his fully owned
company Hermod Farms AS holds 108 227 891 shares in the Company.

Christian Harstad has been allocated 9 900 000 shares in the Company. As a
result, Christian Harstad holds 9 900 000 shares in the company.

For any questions please contact: 
Ingrid Juven, CFO SoftOx Solutions AS 
Mail: ir@soft-ox.com 
Phone: Ingrid Juven: (+47) 918 76 165 

About SoftOx Solutions AS 
SoftOx Solutions AS (SoftOx) is a Medtech, and pharmaceutical company listed on
Euronext Growth Oslo under 'SOFTX'. SoftOx Solutions AS was founded in 2012 and
is headquartered in Oslo. The SoftOx Solutions Group includes the holding
company SoftOx Solutions AS, the Malmö subsidiary Water Innovation AB, and
subsidiaries SoftOx Defense Solutions AS and SoftOx Disinfection AS. SoftOx is
developing a highly effective antimicrobial solution for biofilm, viral, and
antimicrobial-resistant infections. The patent-protected technology is based on
extensive research and development in partnership with leading Nordic research
institutes. 
For more information on SoftOx, visit www.soft-ox.com